Skip to main content

19 May 2026

Last updated: Tuesday 19 May 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The risks of therapeutic genome editing

Sunday 25 June 2017

Interviewee/Contributor

Houria Bachtarzi and Tim Farries

Organisation

ERA Consulting (UK) Ltd

Organisations

Pfizer Regenerative Medicine
apceth GmbH & Co KG
OutSee Ltd
Bellevue Asset Management
ALK-Abelló A/S
Genenta Science SpA
Sofinnova Partners Telethon Strategy
NEO New Oncology AG
MedNous editorial board member
Forendo Pharma Ltd

Interviewees and Contributers

Arndt Schottelius
Cristiana Pires
Donald Light
John Purves
Dr Matthew Wright
Nessa Carey
Iain McGill
John Burt
Dawn Firmin
Aleksandra Grasso

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

New executives at CPTx GmbH

Monday 18 May 2026

Halozyme Therapeutics names former J&J executive as CFO

Monday 18 May 2026

ProBioGen names COO

Monday 18 May 2026

Nadmed appoints new CEO

Monday 18 May 2026

EpilepsyGTx appoints co-founder as CSO

Monday 18 May 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form